Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jun;68(6):2333-2343.
doi: 10.1007/s10620-023-07840-5. Epub 2023 Feb 7.

A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus

Affiliations
Randomized Controlled Trial

A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus

Grace X Ma et al. Dig Dis Sci. 2023 Jun.

Abstract

Background: Hepatitis B virus (HBV) is the leading cause of hepatocellular carcinoma (HCC). Asian Americans have the highest incidence and mortality rates of HCC among all US racial/ethnic groups. Inadequate monitoring and treatment of chronic hepatitis B contribute to poor health outcomes and increased healthcare costs among Asian Americans.

Aims: The goal of this study is to assess the effect of a patient-led strategy on chronic hepatitis B monitoring and treatment adherence specifically among Asian Americans with culturally tailored Patient Navigator-led Intervention.

Methods: From 2015 to 2018, 532 eligible participants living with chronic hepatitis B in the greater Philadelphia and New York city metropolitan areas were randomly assigned to either the intervention group or the control group. Generalized linear mixed-effects models were used to estimate the odds ratio (OR) for rates of doctor visits for chronic hepatitis B and rates of alanine aminotransferase testing for evidence of liver damage.

Results: Intervention group had higher rates of doctor visits than the control group at both 6-month (77.22% vs. 45.75%) and 12-month assessments (90.73% vs. 60.61%). Significantly more intervention group participants received ALT testing than control group participants at 6-month (52.90% vs. 25.10%) and 12-month (75.40% vs. 46.75%) follow-up.

Conclusions: Culturally and linguistically appropriate intervention has strong effects on adherence to follow-up care among Asian American hepatitis B patients experiencing challenges to medication adherence and follow up care. These findings further identify opportunities for practical implementation of evidence-based intervention that could lead to reductions in disparities in chronic liver disease and liver cancer among high-risk, underserved populations.

Trial registration: ClinicalTrials.gov NCT02421666.

Keywords: Asian Americans; Chronic hepatitis B; Monitoring; Treatment adherence.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest No disclosures were reported.

Figures

Fig. 1
Fig. 1
Intervention (PNMI) Group and Comparator (Standard Care) Group. CHB chronic hepatitis B, hepB hepatitis B, HBV hepatitis B virus, PN patient navigator, PNMI patient navigator–led mobile phone text messaging intervention, Viet Vietnamese
Fig. 2
Fig. 2
Flow diagram of the progress through a 2-group parallel randomized trial using Consolidated Standards of Reporting Trials (CONSORT) protocol

References

    1. World Health Organization (2016) Hepatitis B. In: WHO. http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed 7 Apr 2016
    1. Sharma S, Carballo M, Feld JJ, Janssen HLA. Immigration and viral hepatitis. Journal of Hepatology 2015;63:515–522. 10.1016/j.jhep.2015.04.026. - DOI - PubMed
    1. Nguyen K, Van Nguyen T, Shen D, Xia V, Tran D, Banh K, Ruan V, Hu K-Q. Prevalence and Presentation of Hepatitis B and C Virus (HBV and HCV) Infection in Vietnamese Americans via Serial Community Serologic Testing. J Immigr Minor Health 2015;17:13–20. 10.1007/s10903-013-9975-5. - DOI - PubMed
    1. Hepatitis B Foundation (2016) Hepatitis B Foundation: FAQ: General Info. http://www.hepb.org/patients/general_information.htm#ques3. Accessed 7 Apr 2016
    1. El-Serag HB. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma. Gastroenterology 2012;142:1264–1273.e1. 10.1053/j.gastro.2011.12.061. - DOI - PMC - PubMed

Publication types

Associated data